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Hypoxia is a feature of the microenvironment of a growing tumor. The transcription factor NFB is activated in hypoxia, an event that has significant implications for tumor progression. Here, we demonstrate that hypoxia activates NFB through a pathway involving activation of IB kinase-␤ (IKK␤) leading to phosphorylationdependent degradation of IB␣ and liberation of NFB. Furthermore, through increasing the pool and/or activation potential of IKK␤, hypoxia amplifies cellular sensitivity to stimulation with TNF␣. Within its activation loop, IKK␤ contains an evolutionarily conserved LxxLAP consensus motif for hydroxylation by prolyl hydroxylases (PHDs). Mimicking hypoxia by treatment of cells with siRNA against PHD-1 or PHD-2 or the pan-prolyl hydroxylase inhibitor DMOG results in NFB activation. Conversely, overexpression of PHD-1 decreases cytokine-stimulated NFB reporter activity, further suggesting a repressive role for PHD-1 in controlling the activity of NFB. Hypoxia increases both the expression and activity of IKK␤, and site-directed mutagenesis of the proline residue (P191A) of the putative IKK␤ hydroxylation site results in a loss of hypoxic inducibility. Thus, we hypothesize that hypoxia releases repression of NFB activity through decreased PHD-dependent hydroxylation of IKK␤, an event that may contribute to tumor development and progression through amplification of tumorigenic signaling pathways.
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uring cancer progression, a state of hypoxia occurs as the developing tumor outgrows the local blood supply, leading to a drop in pO 2 (1), a condition that should prove rate limiting for tumor growth. However, growth of the tumor is paradoxically facilitated through promotion of a pathway maladaptive for the host involving activation of the hypoxia-specific transcriptional regulator, hypoxia inducible factor-1 (HIF-1), which regulates the expression of genes promoting angiogenesis, vasodilatation, glycolysis, and erythropoesis (2) . Furthermore, hypoxia also activates NFB (3), a transcription factor important in the promotion and progression of tumor development and survival (4) . The net result of HIF-1 and NFB activation by hypoxia is increased tumor oxygenation and survival/growth, respectively. Thus, inhibition of these pathways represents a potentially important therapeutic window of opportunity in the treatment of cancer.
The mechanisms by which HIF-1 is activated in hypoxia are relatively well understood (5) . HIF-1␣ is constitutively synthesized at a high level in normoxia, but its level is repressed by members of the 2-oxoglutarate-dependent dioxygenase superfamily, namely the prolyl hydroxylases (PHDs). Three PHD isoforms have been described to date (PHD-1, PHD-2, and PHD-3). Oxygen-dependent modification of specific proline residues within consensus LxxLAP motifs (P402 and P564) in HIF-1␣ by these enzymes, primarily the PHD-2 isoform, results in the targeting of HIF-1␣ for ubiquitination through an E3 ligase complex initiated by the binding of the Von Hipple Lindau protein (pVHL) and subsequent proteasomal degradation. A further hydroxylation of N803 in the transactivation domain of HIF-1␣ by Factor Inhibiting HIF (FIH), an asparagine hydroxylase, represents a second mechanism of oxygen-dependent repression through inhibition of transactivation (6) . Similar mechanisms exist for HIF-2␣ (5). The hypoxic sensitivity of the HIF pathway is achieved by the absolute requirement of PHD enzymes for molecular oxygen as a cosubstrate. Inhibition of this pathway in hypoxia with the resultant stabilization and transactivation of HIF-␣ subunits represents a paradigm for oxygen sensing and hypoxia-responsive alterations in gene expression (7) .
NFB-like HIF-1 is a prosurvival transcription factor implicated in tumorigenesis through increasing the expression of genes that inhibit apoptosis and growth arrest in premalignant cells and promote tumor progression through production of cytokines (4) . The mechanisms of NFB activation have been best characterized for their role in inflammation in response to a host of proinflammatory ligands (e.g., TNF␣, IL-1, and lipopolysaccharide). A complex sequence of events resulting from receptor occupation by these ligands triggers cascades involving a diverse array of adaptor molecules and enzymes that are ligand-specific (8) . There is, however, a convergence point for these signals at the level of the IB kinases (IKK ␣, ␤, and ␥) that form the IKK complex (9) . Although it is clear that hypoxia activates NFB, the signaling pathways remain unclear. In the current study, we sought to interrogate the signaling pathways leading to NFB activation in hypoxia. We investigated whether similar oxygen-sensing mechanisms that exist for HIF-1 may also exist for NFB. Specifically, we investigated a role for the PHDs.
Results
Hypoxia Activates NFB. Consistent with previous studies, hypoxia activated NFB (10, 11) . Hypoxia stimulated a 1.9 Ϯ 0.1-and 5.9 Ϯ 1.7-fold increase in basal NFB-dependent transcriptional activity at 24 and 48 h, respectively, as measured by the NFB-dependent luciferase reporter assay (Fig. 1A) . Furthermore, this event is preceded by increased levels of nuclear NFB (as demonstrated by p65 binding to immobilized oligonucleotides containing the con-sensus NFB response element) detectable 4 h after exposure to preconditioned hypoxic medium (1.8 Ϯ 0.29-fold; P Ͻ 0.05; 1% O 2 ; Fig. 1B) . Next, cells were exposed to graded hypoxia (21%, 10%, 5%, 3%, and 1% O 2 ) in separate ambient atmospheric hypoxia chambers. Using oxygen quenching oxymetry, we determined extracellular oxygen tensions at the level of the monolayer to be 105 Ϯ 2.9, 67 Ϯ 1.6, 23 Ϯ 1.0, 9 Ϯ 1.0, and 2 Ϯ 0.2 mmHg (1 mmHg ϭ 133 Pa), respectively (Fig. 1C) . DNA binding activity of p65 and HIF-1 in nuclear fractions was measured in the same cell lysates and was related to oxymetry readings. Whereas the peak of p65 DNA binding in hypoxia occurred at a cell pO 2 of 9.2 Ϯ 0.9 mmHg (Fig. 1D) , peak HIF-1 DNA binding occurred at a relatively lower pO 2 value (1.7 Ϯ 0.2 mmHg; Fig. 1E ).
TNF␣-Induced NFB Nuclear Binding Is Enhanced in Hypoxia. To determine possible functional consequences for our observations, we examined whether hypoxia increased cellular sensitivity to a stimulus of the NFB pathway, TNF␣. HeLa cells were exposed to a preconditioned hypoxic medium (1% O 2 for 1 h) before treatment with low doses of TNF␣ (0.01-0.1 ng/ml for 1 h). Nuclear lysates were prepared, and DNA-binding assay was carried out. As predicted, TNF␣-dependent activation of the NFB pathway was significantly enhanced in cells in hypoxia (P Ͻ 0.05; Fig. 2 ).
Hypoxia Activates NFB Through IKK. The IKK complex is the convergence point for many diverse NFB-activating stimuli including TNF␣, LPS, and IL-1 (8) . We investigated whether hypoxiadependent NFB activation involves this pathway. Cells were exposed to a preconditioned hypoxic medium (1% O 2 ), and the phosphorylation status of IKK␣/␤ was determined by Western blot analysis. Hypoxia results in a rapid phosphorylation of the IKK␣/␤ complex detectable after 5 min, which is temporally upstream of IB␣ phosphorylation on S32 and S36 (maximal after 15 min) and, in turn, is temporally upstream of IB␣ degradation (Fig. 3A) . The transient nature of IB␣ phosphorylation is consistent with reports of the cyclical nature of NFB activation in response to other stimuli (12) . Critically, these measurements were made in the same cell lysates. Thus, hypoxia likely activates NFB through IKKdependent mechanisms. Abolition of HIF-1 expression in HeLa cells using siRNA did not alter hypoxia-induced IB␣ phosphorylation ( Fig. 3B ), indicating that hypoxia-induced activation of the NFB pathway is independent of HIF-1␣.
PHD Inhibition Stimulates NFB Activity. Prolyl hydroxylases are central to oxygen-sensing pathways leading to HIF-1␣ activation as a result of their absolute requirement upon molecular oxygen as a cofactor for enzymatic activity (2). The above data led us to the hypothesis that decreased PHD activity in hypoxia may also underlie NFB activation. To further test this, we examined components of the NFB pathway for the presence of the previously described, conserved LxxLAP motif for proline hydroxylation in HIF-1␣ (13) . Whereas p65, p50, IB␣, and NEMO (IKK␥) are without this sequence, both IKK␣ and IKK␤ contain the motif (Fig. 4A ). This motif is evolutionarily conserved between humans, mice, and zebrafish. Interestingly, this motif is adjacent to the sites of phosphorylation of IKK␤ (177/181) on the activation loop, making it likely accessible to modification by enzymes such as PHDs. To investigate the possibility that PHDs are playing a role in NFB activation in hypoxia, we used PHD isoform-specific siRNA (14) . Using this approach, we effectively knocked down each of the PHD-1, -2, and -3 isoforms by 73.3%, 80.3%, and 93.6%, respectively. Quantitation of PHD knockdown as measured by quantitative RT-PCR is demonstrated in Fig. 4B . Knockdown of each individual PHD isoform was without effect on expression levels of the other isoforms as measured by quantitative RT-PCR. HeLa cells transfected with an HIF-1-dependent luciferase reporter construct demonstrated sensitivity to PHD-2 knockdown as previously reported (ref. 13 and data not shown). Interestingly, cells transfected with an NFBdependent reporter construct demonstrated the greatest reporter activity in cells deficient in the PHD-1 isoform, indicating that the dominant isoform specificity for PHDs may differ for the HIF-1 and NFB pathways (Fig. 4C) . Conversely, artificial transient overexpression of PHD-1 in normoxia causes a decrease in TNF␣-stimulated NFB activity (Fig. 4D) .
HeLa cells transfected with an NFB-luciferase reporter construct were treated in normoxia with the pan-hydroxylase inhibitor DMOG (1 mM) for 24 h. DMOG treatment resulted in a 2.2 Ϯ 0.4-fold increase in NFB reporter activity compared with vehicletreated control cells (P Ͻ 0.05, n ϭ 4; Fig. 4E ). To assess whether DMOG was acting proximally, at the level of initiation of the NFB response, we exposed HeLa cells to 1 mM DMOG over a short time course (0-75 min) and demonstrated phosphorylation of S32/36 residues of IB␣, which was maximal after a 30-min exposure (Fig.  4F) , thus indicating that PHD inhibition increases IKK activity. Collectively, these data indicate a repressive role for PHD-1 in NFB signaling. Furthermore, PHD inhibition by DMOG (1 mM, 24 h) or PHD1 siRNA caused a significant increase in the expression of COX-2, an important NFB-dependent inflammatory marker (Fig. 4 G and H) .
Hypoxia Alters the Cellular Pool of IKK␣ and IKK␤. HIF-1 stability is controlled by the PHD-dependent hydroxylation of specific residues in the CODD and NODD regions. The presence of an HIF-␣ LxxLAP consensus motif in IKK␤ led us to examine the expression of these proteins under hypoxia. In line with previous studies (15) , HeLa cells exposed to graded hypoxia for 24 h demonstrated increased IKK␤ protein levels, whereas IKK␥/ NEMO (which does not contain the hydroxylation motif) did not increase (Fig. 5A) . We next investigated the impact of hypoxia on IKK␤ expression in more physiologically relevant cell lines of immune and epithelial origin. Similar to HeLa cells, IKK␤ levels were increased by graded hypoxia in THP-1 monocytic cells and in CaCo-2 intestinal epithelial cells in response to instantaneous hypoxia (1% O 2 ) (Fig. 5B) .
Because IKK␤ has been described as the primary positive regulator of NFB activity in inflammatory processes and as the molecular link between inflammation and cancer (16-18), we focused our subsequent studies on this isoform. To assess the role of the proline residue within the LxxLAP motif of IKK␤ (P191), we used a site-directed mutagenesis strategy to mutate P191 to an alanine residue. HeLa cells were transiently transfected with wild-type IKK␤ or P191A IKK␤ DNA. Forty-eight hours after transfection, cells were exposed to normoxia or preconditioned hypoxic medium (3% O 2 for 2 h; pO 2 ϭ 19.9 mmHg). Cytosolic extracts were prepared, and IKK␤ expression levels were compared by Western blot analysis. Cells transfected with the wild-type vector demonstrated elevated levels of IKK␤ in hypoxia. Cells transfected with the P191A IKK␤ vector demonstrated a loss of hypoxic inducibility (Fig. 5C ). This is suggestive of a key role for P191 in the hypoxic regulation of IKK␤ levels.
Interestingly, digital residue replacement modeling indicates that a modeled IKK peptide containing the LxxLAP motif has the characteristic boomerang structure of the HIF-1 CODD sequence, which is also subject to prolyl hydroxylation by PHDs (19) . Furthermore, based on the crystal structure of the HIF-1 CODD peptide interaction with VHL (19), we were able to model an IKK␤-pVHL interaction without having to drastically modify the pVHL structure (data not shown).
Coimmunoprecipitation studies demonstrate an interaction between VHL and IKK␤ in normoxic cells (Fig. 5D) ; however, this does not appear to result in ubiquitination or proteasomal degradation of IKK␤ (data not shown). Furthermore, coimmunoprecipitation studies reveal the interaction between PHD1 and both IKK ␣ and ␤ isoforms. Although this indirectly indicates that IKK is hydroxylated, further critical experimentation using mass spectrometric analysis will be necessary to directly demonstrate hydroxylation. A distinct possibility is that inhibition of IKK activity by hydroxylation of P191 may be due to steric hindrance of the phosphorylation of the nearby residues S177 and S181 within the activation loop. Alternatively, binding of VHL to hydroxylated IKK may prevent activation through the blockage of the serine phosphorylation residues on the activation loop. Thus, we propose that hydroxylation represses IKK␤ activity by altering protein expression or by preventing its activation through phosphorylation on S177/S181. Discussion PHD enzymes are critical in sensing and transducing the HIFdependent transcriptional response to hypoxia, an event clearly demonstrating an absolute requirement for molecular oxygen as a cosubstrate (7, 20) . Thus, PHDs are true oxygen/hypoxia sensors. However, the transcriptional response to hypoxia is not restricted to HIFs with NFB also demonstrating hypoxic sensitivity and impacting the resultant hypoxic transcriptome (3). However, to date, our understanding of PHD involvement in hypoxic signaling has been restricted mainly to the HIF-1 pathway. Because of its role in tumor progression, NFB has important pathophysiologic implications in cancer, a condition involving significant tissue hypoxia.
Hypoxia-activated NFB is demonstrable by the nuclear accumulation of the p65 subunit as well as by reporter gene assay and correlates with decreased cellular pO 2 . Furthermore, hypoxiainduced NFB activity is preceded by temporally sequential IKK activation, IB phosphorylation, and IB degradation, indicating that hypoxia activates NFB through increased IKK activity. The IKK-dependence of hypoxia-induced NFB activity is consistent with most other stimuli of this pathway. Although previous studies have hypothesized roles for tyrosine phosphorylation (21) , reactive oxygen species generation (22) , and p42/44 or PI-3-kinase (23) in mediating NFB responses in hypoxia, none of these theories clearly demonstrates a direct relationship between decreased molecular oxygen and NFB activation such as through altered PHD activity. Our model proposes that while hypoxia activates NFB it also increases the sensitivity of the NFB pathway to activation through proinflammatory stimuli, such as cytokines. Thus, the importance of this pathway may be greatest where hypoxia occurs against the backdrop of increased inflammatory activity [such as in a growing tumor (24) ] where amplification of a stimulated response may heavily affect tumor-promoting gene expression.
Alternative signaling targets for proline hydroxylation in the transcriptional response to hypoxia are attractive in developing the theory that hydroxylating enzymes are central to cellular oxygen sensing (7, 20) . In the current study, we demonstrate that IKK␤, a critical regulator of NFB activity, contains a conserved prolyl hydroxylation consensus site homologous with the two conserved sites within the oxygen-dependent degradation domain (ODD) of HIF-1 (LxxLAP). Like HIF-1␣, the pool of IKK␤ in cells is increased in hypoxia; however, unlike HIF␣, the absolute expression of IKKs is not determined by the presence of oxygen because basal expression is clearly detectable. Thus, it appears that hypoxia is more a modulator of IKK expression and activation than an absolute determinant. This may be due to the presence of just a single LxxLAP motif in IKK␤ rather than the two present in HIF-1␣. A recent study has demonstrated the requirement of a leucine residue within 10 residues of the LxxLAP motif for hydroxylation of the consensus motif (25) . Two leucine residues reside closely downstream of the LxxLAP motif in IKK␤. Importantly, the putative site of hydroxylation (P191) on IKK␤ resides just 10 residues from the known phosphorylation site S181, which is required for IKK␤ activation. S181 is positioned in the vicinity of P191 in the well conserved protein kinase activation loop, and P191 itself is predicted to be positioned in the substrate binding cleft. Experimental studies (26) of a prototypic protein kinase (the cAMP-dependent protein kinase, PKA) show that the conformation and dynamics of the activation loop are known to be linked with the phosphorylation of S181. Thus, it is possible that hydroxylation of P191 alters the conformation of the activation loop, making phosphorylation difficult or ineffective (i.e., the kinase might be phosphorylated but inactive) and/or impairs the binding of the protein kinase substrate. This would cause a decrease in IKK␤ (and subsequently NFB) activity. Similarly, it is also conceivable that phosphorylation renders hydroxylation more difficult because the hydroxylation site in active IKK␤ could be masked by the substrate. Additionally, the activation loop would be less dynamic and hence less accessible to PHDs.
The role of IKK␤ in oncogenesis and inflammation is well established, but there is emerging evidence that IKK␣ may have antiinflammatory functions (27, 28) . We also observed an increase in IKK␣ in hypoxia (data not shown). The observation that both IKK␣ and IKK␤ are hypoxia-sensitive, albeit differentially, suggests the possibility of a counterbalancing mechanism where a p65-mediated response could be resolved over a course of hypoxia.
Genetic or pharmacologic interference with PHD activity results in activation of NFB-dependent signaling in normoxia. Mutation of the hydroxylated proline residues of HIF-1␣ results in a loss of hypoxic inducibility (29) . Similarly, mutation of proline residue 191 in IKK␤, which resides within the consensus sequence, results in a similar effect. Although sensitive to knockdown of both PHD-1 and PHD-2, NFB activation appears to be more sensitive to silencing of the PHD-1 isoform, suggesting somewhat differential regulation to HIF-1, which is predominantly regulated by PHD-2. These data suggest the intriguing possibility that hypoxia increases IKK stability through an inhibition of protein hydroxylation, resulting in evasion of degradation in a similar manner to HIF-1. Indeed, it is worth noting that a number of studies have demonstrated that the E3 pVHL suppresses NFB activity in normoxia (30) (31) (32) . However, although IKK␤ interacts with VHL in normoxia, we found no evidence for its ubiquitination/degradation. Furthermore, the rapid kinetics of IKK␤ activation in hypoxia suggests the likelihood that the primary repressive role of P191 hydroxylation would be through inhibition of phosphorylation of S177/S181. This may occur through VHL masking of the activation loop.
Thus, hypoxia increases the expression and activation of IKK, leading to increased sensitivity of cells to inflammatory stimuli such as cytokines. This has important implications in cancer where elevated levels of proinflammatory cytokines coexist with hypoxia in the microenvironment of the tumor (33) . Furthermore, this is consistent with previous studies demonstrating synergy between hypoxia and inflammatory cytokines in the activation of cells (10, 34) .
In summary, we propose that hypoxia, through inhibiting PHD activity, increases the activity of cellular IKK␤, an event that amplifies the cellular capacity for response to cytokines. Furthermore, we believe that such events may directly impact on tumor development through enhanced expression of genes that promote tumor development and growth.
Methods
Cell Culture and Hypoxia. HeLa, CaCo-2, and THP-1 cells were placed in one of four hypoxia chambers (Coy Laboratories, Grass Lake, MI; Ruskin Technologies, Leeds, U.K.) allowing the establishment of graded, humidified, ambient, atmospheric hypoxia of 21%, 10%, 5%, 3%, and 1% O 2 with 5% CO 2 and a balance of N 2 in all cases. Extracellular pO 2 measurements were made by using fluorescence quenching oxymetry (Oxylite-2000; Oxford Optronix, Oxford, U.K.). Hypoxia did not induce apoptosis or necrosis (data not shown). Temperature was maintained at 37°C. Where outlined, instantaneous hypoxia was achieved by exposure of cells in hypoxia chambers to preconditioned media.
Western Blot Analysis. Cytoplasmic or whole-cell lysates were separated by SDS/PAGE, transferred to nitrocellulose membranes, and immunoblotted as described (35) . IKK␣, IKK␤, and phospho-IKK␣ (S180)/IKK␤ (S181) polyclonal antibodies (Cell Signaling), IKK␥/NEMO polyclonal antibody (Santa Cruz Biotechnology), IB␣ polyclonal antibody (Upstate Biotechnology), FLAG poly- Forty-eight hours after transfection, the cells were maintained in normoxia (N; 21% O2) or exposed to preconditioned hypoxic medium (H; 3% O 2) for 2 h. Cytosolic extracts were immunoblotted for IKK␤ and ␤-actin. Alterations in protein expression were measured semiquantitatively by using densitometric analysis (n ϭ 4). (D) pVHL was immunoprecipitated from whole HeLa cell extracts (500 or 1,000 g of total protein), and immunoprecipitates were immunoblotted for IKK␤ and hexokinase (similarly sized negative control). (E) NETN lysates from HeLa cells transiently overexpressing PHD-1-FLAG were immunoprecipitated by using a specific anti-FLAG resin. Immunoprecipitates were immunoblotted for IKK␤, IKK␣, FLAG, and hexokinase.
